BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mursaleen L, Noble B, Somavarapu S, Zariwala MG. Micellar Nanocarriers of Hydroxytyrosol Are Protective against Parkinson's Related Oxidative Stress in an In Vitro hCMEC/D3-SH-SY5Y Co-Culture System. Antioxidants (Basel) 2021;10:887. [PMID: 34073115 DOI: 10.3390/antiox10060887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Leow DM, Cheah IK, Fong ZW, Halliwell B, Ong W. Protective Effect of Ergothioneine against 7-Ketocholesterol-Induced Mitochondrial Damage in hCMEC/D3 Human Brain Endothelial Cells. IJMS 2023;24:5498. [DOI: 10.3390/ijms24065498] [Reference Citation Analysis]
2 Sarkar A, Rasheed MSU, Singh MP. Redox Modulation of Mitochondrial Proteins in the Neurotoxicant Models of Parkinson's Disease. Antioxid Redox Signal 2023. [PMID: 36401516 DOI: 10.1089/ars.2022.0106] [Reference Citation Analysis]
3 Mursaleen L, Chan SHY, Noble B, Somavarapu S, Zariwala MG. Curcumin and N-Acetylcysteine Nanocarriers Alone or Combined with Deferoxamine Target the Mitochondria and Protect against Neurotoxicity and Oxidative Stress in a Co-Culture Model of Parkinson's Disease. Antioxidants (Basel) 2023;12. [PMID: 36670992 DOI: 10.3390/antiox12010130] [Reference Citation Analysis]
4 Katari O, Yadav S, Akhtar J, Jain S. Micelles-based drug delivery for dementia. Nanomedicine-Based Approaches for the Treatment of Dementia 2023. [DOI: 10.1016/b978-0-12-824331-2.00002-9] [Reference Citation Analysis]
5 Witika BA, Poka MS, Demana PH, Matafwali SK, Melamane S, Malungelo Khamanga SM, Makoni PA. Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date. Pharmaceutics 2022;14:836. [DOI: 10.3390/pharmaceutics14040836] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]